Germline mutations in BRCA1/BRCA2 lead to a hereditary cancer predisposition syndrome that can increase the risk of ovarian, breast, prostate, and pancreatic cancer, among others [1–3]. The gene discussed is BRCA2; the disease is pancreatic neoplasm.